Corrigendum to “The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer's disease pathology” [Europ. J. Med. Chem. Rep. 12 (2024) 100193] - Vaia-Argyro Bakalakou; Barbara Mavroidi; Amalia D. Kalampaliki; Béatrice Josselin; Stéphane Bach; Alexios-Leandros Skaltsounis; Panagiotis Marakos; Nicole Pouli; Maria Pelecanou; Vassilios Myrianthopoulos; Sandrine Ruchaud; Ioannis K. Kostakis (European Journal of Medicinal Chemistry Reports)